Literature DB >> 11228544

Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.

L Thorstensen1, H Qvist, S Heim, G J Liefers, J M Nesland, K E Giercksky, R A Lothe.   

Abstract

Cytogenetic and molecular genetic analyses of colorectal adenomas and carcinomas have shown that loss of the distal part of chromosome arm 1p is common, particularly in tumors of the left colon. Because the importance of 1p loss in colorectal cancer metastases is unknown, we compared the frequency, exact site and extent of 1p deletions in primary carcinomas (n=28), local recurrences (n=19) and metastases (n=33) from 67 colorectal cancer patients using 14 markers in an allelic imbalance study. Loss of 1p was found in 50% of the primary carcinomas, 33% of the local recurrences, and 64% of the metastases, revealing a significant difference between the local recurrences and the metastases (P=.04). The smallest region of 1p deletion overlap (SRO) defined separately for each group of lesions had the region between markers D1S2647 and D1S2644, at 1p35-36, in common. The genes PLA2G2A (1p35.1-36) and TP73 (1p36.3) were shown to lie outside this consistently lost region, suggesting that neither of them are targets for the 1p loss. In the second part of the study, microdissected primary carcinomas and distant metastases from the same colorectal cancer patients (n=18) were analyzed, and the same 1p genotype was found in the majority of patients (12/18, 67%). The finding that primary carcinoma cells with metastatic ability usually contain 1p deletions, and that some cases lacking 1p alterations in the primary tumor acquire such changes during growth of a metastatic lesion, supports the notion that 1p loss may be important both early and late in colorectal carcinogenesis, with the apparent exception of local recurrences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11228544      PMCID: PMC1508083          DOI: 10.1038/sj.neo.7900111

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  44 in total

1.  Karyotype peculiarities of human colorectal adenocarcinomas.

Authors:  L N Konstantinova; E W Fleischman; V I Knisch; A G Perevozchikov; B P Kopnin
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

2.  Allelotype of colorectal carcinomas.

Authors:  B Vogelstein; E R Fearon; S E Kern; S R Hamilton; A C Preisinger; Y Nakamura; R White
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

3.  Cytogenetics of colorectal adenocarcinomas.

Authors:  M Muleris; R J Salmon; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1990-06

4.  Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis.

Authors:  G Bardi; N Pandis; C Fenger; O Kronborg; L Bomme; S Heim
Journal:  Cancer Res       Date:  1993-04-15       Impact factor: 12.701

5.  Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma.

Authors:  K Ookawa; M Sakamoto; S Hirohashi; Y Yoshida; T Sugimura; M Terada; J Yokota
Journal:  Int J Cancer       Date:  1993-02-01       Impact factor: 7.396

6.  Loss of heterozygosity at the human RAP1A/Krev-1 locus is a rare event in colorectal tumors.

Authors:  J Young; J Searle; R Stitz; A Cowen; M Ward; G Chenevix-French
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

7.  Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features.

Authors:  G Bardi; B Johansson; N Pandis; E Bak-Jensen; C Orndal; S Heim; N Mandahl; A Andrén-Sandberg; F Mitelman
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

8.  Human colorectal cancer: high frequency of deletions at chromosome 1p35.

Authors:  I Leister; A Weith; S Brüderlein; C Cziepluch; D Kangwanpong; P Schlag; M Schwab
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Chromosome 1 in human colorectal tumors. Cytogenetic research on structural changes and their significance.

Authors:  M H Couturier-Turpin; C Esnous; A Louvel; Y Poirier; D Couturier
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

10.  Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.

Authors:  G I Meling; R A Lothe; A L Børresen; S Hauge; C Graue; O P Clausen; T O Rognum
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

View more
  7 in total

1.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.

Authors:  Aung Ko Win; Sean P Cleary; James G Dowty; John A Baron; Joanne P Young; Daniel D Buchanan; Melissa C Southey; Terrilea Burnett; Patrick S Parfrey; Roger C Green; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; Noralane M Lindor; John L Hopper; Steven Gallinger; Mark A Jenkins
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

Review 3.  Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review.

Authors:  Christin Lund-Andersen; Annette Torgunrud; Karianne Giller Fleten; Kjersti Flatmark
Journal:  J Gastrointest Oncol       Date:  2021-04

4.  miR-34a repression of SIRT1 regulates apoptosis.

Authors:  Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-28       Impact factor: 11.205

5.  1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer.

Authors:  Markus Mayrhofer; Hanna Göransson Kultima; Helgi Birgisson; Magnus Sundström; Lucy Mathot; Karolina Edlund; Björn Viklund; Tobias Sjöblom; Johan Botling; Patrick Micke; Lars Påhlman; Bengt Glimelius; Anders Isaksson
Journal:  BMC Cancer       Date:  2014-11-24       Impact factor: 4.430

6.  Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth.

Authors:  Tatjana Pandzic; Veronica Rendo; Jinyeong Lim; Chatarina Larsson; Jimmy Larsson; Ivaylo Stoimenov; Snehangshu Kundu; Muhammad Akhtar Ali; Mats Hellström; Liqun He; Anders M Lindroth; Tobias Sjöblom
Journal:  Oncotarget       Date:  2017-10-09

Review 7.  MUTYH the base excision repair gene family member associated with colorectal cancer polyposis.

Authors:  Seyed Mohammad Hossein Kashfi; Mina Golmohammadi; Faeghe Behboudi; Ehsan Nazemalhosseini-Mojarad; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.